Ulrich Schüller

Oncogene aberrations drive medulloblastoma progression, not initiation

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant

crossNN is an explainable framework for cross-platform DNA methylation-based classification of tumors

The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis

PLAG1 fusions define a third subtype of CNS embryonal tumor with PLAG family gene alteration

European standard clinical practice recommendations for newly diagnosed ependymoma of childhood and adolescence

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models

Recurrence patterns in pediatric intracranial ependymal neoplasm: a systematic imaging work-up

The HIT-network for children and adolescents with CNS tumors facilitates improvements of diagnostic assessments, multimodal treatments, individual counselling, and research in Germany, Austria, and Switzerland

Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a <i>PDGFRA</i> inhibitor trial

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries

CNSC-81. H3G34-MUTANT DIFFUSE HEMISPHERIC GLIOMAS CONTAIN CELLULAR NICHES OF GABAERGIC INTERNEURON-LIKE CELLS WITH DUAL FREQUENCY AUTONOMOUS RHYTHMIC CALCIUM ACTIVITY

A prognostic neural epigenetic signature in high-grade glioma

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant

Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features

Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas

EpiDiP/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnostics

Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level

Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance

Nanopore sequencing from formalin-fixed paraffin-embedded specimens for copy-number profiling and methylation-based CNS tumor classification

Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation

Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator

Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology

Morphology‐based molecular classification of spinal cord ependymomas using deep neural networks

Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations

Distinct relapse pattern across molecular ependymoma types

Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors

Single-cell transcriptomics link gene expression signatures to clinicopathological features of gonadotroph and lactotroph PitNET